Some trues concerning coffee;Algunas verdades sobre el café

Revista Chilena de Nutricion

Volumn 34, Issue 2, 2007, Pages 105-115

  Gotteland, Martín ^a,b   De Pablo V , Saturnino ^b  

^a Laboratorio de Microbiología Y Probióticos

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Antioxidant; Cardiovascular diseases; Chlorogenic acid; Coffee; Parkinson; Type 2 diabetes

Indexed keywords

EID: 34848881366     PISSN: 07177518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Belitz HD, Grosch W. Food Chemistry. Springer-Verlag, Berlin 1999.
2. Mundo del Café, http://www.mundodelcafe.com/historia.htm
3. International Coffee Organization, http://www.ico.org/
4. International Coffee Organization, ICO Annual Review 2004/2005
5. FAO. Bases de Datos FAOSTAT. http://faostat.fao.org/
6. Spiller MA. The chemical components of coffee. Gene A. Spiller, ed. Caffein. CRC Press 1998, p. 103-167.
7. USDA National Nutrient Database for Standard Reference Release 18, Nutrient Data Laboratory, Agricultural Research Service. http://www.nal.usda. gov/fnic/foodcomp/Data/SR18/sr18.html
8. Nestlé. Información Nutricional Nescafé Tradición
9. European Coffee Science Information Centre, CoSIC. http://www.cosic.org/
10. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 1997; 35: 547-554.
11. Urgert, R., van derWeg, G., Kosmeijer-Schuil, T.G., van de Bovenkamp, P., Hovenier, R., and Katan, M.B.. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995; 43: 2167-2172.
12. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001; 153: 353-362.
13. Mattila P, Hellstrom J, Torronen R. Phenolic acids in berries, fruits and beverages. J Agric Food Chem 2006; 54: 7193-7199.
14. Daglia M, Racchi M, Papetti A, Lanni C, Govoni S, Gazzani G. In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee. J Agric Food Chem 2004; 52: 1700-1704.
15. Goodman BA, Glidewell SM, Deighton N, Morrice AE. Free radical reactions involving coffee. Food Chem 1994; 51: 399-403.
16. Shi X, Dalal XS, Jain AC. Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol 1991; 29: 1-6.
17. Devasagayam TP, Kamat JP, Mohan H, Kesavan PC. Caffeine as an antioxidant: inhibition of lipoperoxidation induced by reactive oxygen species. Biochim Biophys Acta 1996; 1282: 63-70.
18. del Castillo MD, Ames JM, Gordon MH. Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 2002; 50: 3698-3703.
19. Svilaas A, Sakhi AK, Andersen LF, Svillas T, Strom EC, Jacobs DR Jr, Ose L, Blomhoff R. Intakes of antioxidants in coffee, wine and vegetables are correlated with plama carotenoids in humans. J Nutr 2004; 134: 562-567.
20. Pulido R, Hernández-García M, Saura-Calixto F. Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 2003; 57: 1275-1282.
21. Pellegrini N, Serafini M, Colombi B, del Rio D, Salvatore S, Bianchi M, Brighenti F. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr 2003; 133: 2812-2819.
22. Halvorsen B, Carlsen M, Phillips KM, Bohn SK, Holte K, Jacobs DR Jr, Blomhoff R. Content of redox-active compounds (ie, antioxidants) in foods consumed in the United States. Am J Clin Nutr 2006; 84: 95-135.
23. Hidgon J, Frei B. Coffee and Health. Crit Rev Food Sci Nutr 2006; 46(2):101-123.
24. Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in human after coffee consumption. J Agric Food Chem 2002; 50: 5735-5741.
25. Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 2002; 50: 6211-6216.
26. Garsetti M, Pellegrini N, Baggio C, Brighetti F. Antioxidant activity in human faeces. Br J Nutr 2000; 84: 705-710.
27. Klatsky AL, Morton C, Udatsova N, Friedman GD. Coffee, cirrhosis and transaminase enzymes. Arch Intern Med 2006; 166: 1190-1195.
28. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003; 13: 419-423.
29. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24-32.
30. Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97: 293-300.
31. Ozercan IH, Dagli AF, Ustundag B, Ozercan MR, Bahcecioglu IH, Celik H, Yalniz M, Poyrazoglu OK, Ataseven H. Does instant coffee prevent acute liver injury induced by carbon tetrachloride (CCl4)? Hepatol Res 2006; 35:163-168.
32. Perez-Bravo F, Carrasco E, Santos JL, Calvillan M, Larenas G, Albala C. Prevalence of type 2 diabetes and obesity in rural Mapuche population from Chile. Nutrition 2001; 17: 236-238.
33. Albala C, Vio F, Kain J, Uauy R. Nutrition transition in Chile: determinants and consequences. Public Health Nutr 2002; 5: 123-128.
34. Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 2001; 50: 2349-2354.
35. Keijzers GB, De Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 2002; 25: 364-369.
36. Petrie HJ, Chown SE, Belfie LM, Duncan AM, McLaren DH, Conquer JA, Graham TE. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 2004; 80: 22-28.
37. Biaggioni I, Davis SN. Caffeine: a cause of insulin resistance? Diabetes Care 2002; 25: 399-400.
38. Thong FS, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 2002; 92: 2347-2352.
39. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477-1478.
40. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004; 255: 89-95.
41. Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N, Hilding A, Ostenson CG. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004; 255: 645-652.
42. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004; 291: 1213-1219.
43. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE Leitzmann MF, Stampfer MJ, Hu FB. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004; 140: 1-8.
44. Paynter NP, Yeh HC, Voutilainen S, Schmidt MI, Heiss G, Folsom AR, Brancati FL, Kao WH.. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 2006; 164: 1075-1084.
45. Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006; 166: 1311-1316.
46. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006; 144: 554-562.
47. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006; 29: 398-403.
48. van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Hoorn study. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 2004; 47: 2152-2159.
49. Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and post-obese human volunteers. Am J Clin 1989; 49: 44-50.
50. Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr 2001; 73: 532-538.
51. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981; 67:1111-1117.
52. McCarty MF. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med Hypotheses 2005; 64: 848-853.
53. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003; 78: 728-733.
54. Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, Graham TE, Wasserman DH. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 2003; 133: 3529-3532.
55. Atanasov AG, Dzyakanchuk AA, Schweizer RA, Nashev LG, Maurer EM, Odermatt A. Coffee inhibits the reactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: a glucocorticoid connection in the anti-diabetic action of coffee? FEBS Lett 2006; 580: 4081-4085.
56. Nygard O, Refsum H, Ueland PM, Stensvold I, Nordrehaug JE, Kvale G, Vollset SE. Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 1997; 65:136-143.
57. Grubben MJ, Boers GH, Blom HJ, Broekhuizen R, de Jong R, van Rijt L, de Ruijter E, Swinkels DW, Nagengast FM, Katan MB. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr 2000; 71: 480-484.
58. Christensen B, Mosdol A, Retterstol L, Landaas S, Thelle DS. Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol - a randomized controlled trial. Am J Clin Nutr 2001; 74: 302-307.
59. Urgert R, van Vliet T, Zock PL, Katan MB. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers. Am J Clin Nutr 2000; 72: 1107-1110.
60. Esposito F, Morisco F, Verde V, Ritieni A, Alezio A, Caporaso N, Fogliano V. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment Pharmacol Ther 2003; 17: 595-601.
61. Verhoef P, Pasman WJ, Van Vliet T, Urgert R, Katan MB. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr 2002; 76: 1244-1248.
62. Strandhagen E, Zetterberg H, Aires N, Palmer M, Rymo L, Blennow K, Landaas S, Thelle DS. The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study. Int J Mol Med 2004; 13: 811-815.
63. Strandhagen E, Landaas S, Thelle DS. Folic acid supplement decreases the homocysteine increasing effect of filtered coffee. A randomised placebo-controlled study. Eur J Clin Nutr 2003; 57:1411-1417.
64. D'Avanzo B, Santoro L, Nobill A, La Vecchia C. Coffee consumption and serum cholesterol. GISSI-EFRIM Study Group. Prev Med 1993; 22: 219-224.
65. Strandhagen E, Thelle DS. Filtered coffee raises serum cholesterol: results from a controlled study. Eur J Clin Nutr. 2003; 57: 1164-1168.
66. Thelle DS, Arnesen E, Forde OH. The Tromso heart study. Does coffee raise serum cholesterol? N Engl J Med 1983; 308:1454-1457.
67. Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA. Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lipid Res 1998; 39: 901-912.
68. Post SM, de Wit EC, Princen HM. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 1997; 17: 3064-3070.
69. van Tol A, Urgert R, de Jong-Caesar R, van Gent T. The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans. Atherosclerosis 1997; 132: 251-254.
70. de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN, Katan MB, Packard CJ. The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects. Am J Clin Nutr 2001; 73: 45-52.
71. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000; 2283: 2674-2679.
72. Jee SH, He J, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999; 33: 647-652.
73. Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ 1990; 300: 566-569.
74. Hakim AA, Ross GW, Curb JD, Rodriguez BL, Burchfiel CM, Sharp DS, Yano K, Abbott RD. Coffee consumption in hypertensive men in older middle-age and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol 1998; 51: 487-494.
75. Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middleaged Swedish men: findings from the Primary Prevention Study. J Intern Med 1991; 230: 67-71.
76. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, Speizer FE, Hennekens CH. Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 1996; 275: 458-462.
77. Murray SS, Bjelke E, Gibson RW, Schuman LM. Coffee consumption and mortality from ischemic heart disease and other causes: results from the Lutheran Brotherhood study, 1966-1978. Am J Epidemiol 1981; 113: 661-667.
78. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 2000; 160: 3393-3400.
79. Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 1999; 53: 481-487.
80. Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006; 83: 1039-1046.
81. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 1993; 4: 366-374.
82. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 1994; 72: 269-275.
83. Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med 1992; 152: 1767-1772.
84. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004; 255: 89-95.
85. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 2003; 133: 3228-3232.